UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Satisfaction and convenience of chelation therapy in patients with sickle cell disease (SCD): Comparison between deferasirox (Exjade((R)), ICL670) and deferoxamine (DFO).

Vichinsky, E and Fischer, R and Pakbaz, Z and Onyekwere, O and Porter, J and Swerdlow, P and Coates, T and Lane, P and Files, B and Mueller, BU and Coic, L and Forni, G and Abetz, L and Baladi, JF and Ressayre-Djaffer, C and Gathmann, I and Alberti, D and Marks, P (2005) Satisfaction and convenience of chelation therapy in patients with sickle cell disease (SCD): Comparison between deferasirox (Exjade((R)), ICL670) and deferoxamine (DFO). In: BLOOD. (pp. 656A - 657A). AMER SOC HEMATOLOGY

Full text not available from this repository.


Type:Proceedings paper
Title:Satisfaction and convenience of chelation therapy in patients with sickle cell disease (SCD): Comparison between deferasirox (Exjade((R)), ICL670) and deferoxamine (DFO).
Event:47th Annual Meeting of the American-Society-of-Hematology
Location:Atlanta, GA
Dates:2005-12-10 - 2005-12-13
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Wolfson Institute and Cancer Institute Administration > Cancer Institute > Research Department of Haematology

Archive Staff Only: edit this record